Literature DB >> 9711339

Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis.

O Erel1, A Kocyigit, M S Gurel, V Bulut, A Seyrek, Y Ozdemir.   

Abstract

Adenosine deaminase (ADA) activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis were investigated and compared with control groups. Fifty patients and 50 healthy individuals were studied. The clinical diagnosis was parasitologically confirmed by culture and Giemsa stain. ADA activities were measured by colorimetric method. Serum ADA activities 37.80 +/- 11.90, 18.28 +/- 6.08 IU/L (p < 0.0001), lymphocyte specific ADA activities 14.90 +/- 7.42, 8.38 +/- 7.42 U/mg protein (p = 0.04), granulocyte specific ADA activities 1.15 +/- 0.73, 1.09 +/- 0.67 U/mg protein (p > 0.05) were found in patients and control groups, respectively. ADA activity increases in some infectious diseases were cell mediated immune mechanisms are dominant. In cutaneous leishmaniasis, lymphokine-mediated macrophage activity is the main effector mechanism. Increase in serum and lymphocyte ADA activities in patients with cutaneous leishmaniasis may be dependent on and reflects the increase in phagocytic activity of macrophages and maturation of T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9711339     DOI: 10.1590/s0074-02761998000400014

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  10 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Adenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii.

Authors:  Verônica S P Castro; Victor C Pimentel; Aleksandro S Da Silva; Gustavo R Thomé; Patrícia Wolkmer; Jorge L C Castro; Márcio M Costa; Cássia B da Silva; Daniele C Oliveira; Sydney H Alves; Maria R C Schetinger; Sonia T A Lopes; Cinthia M Mazzanti
Journal:  Mycopathologia       Date:  2011-12-15       Impact factor: 2.574

3.  Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

Authors:  Yuquan Shao; Ping Xia; Tao Zhu; Jiong Zhou; Yuan Yuan; Hao Zhang; Jianjun Chen; Xingyue Hu
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

4.  Assessment of adenosine deaminase (ADA) activity and oxidative stress in patients with chronic tonsillitis.

Authors:  Mehmet Fatih Garca; Halit Demir; Mahfuz Turan; Nazım Bozan; Ahmet Kozan; Şeyda Bayel Belli; Ayşe Arslan; Hakan Cankaya
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-04       Impact factor: 2.503

5.  A Hospital Based Study on Estimation of Adenosine Deaminase Activity (ADA) in Cerebrospinal Fluid (CSF) in Various Types of Meningitis.

Authors:  Ashok Kumar Agarwal; Sonia Bansal; Vidya Nand
Journal:  J Clin Diagn Res       Date:  2014-02-03

6.  Cerebrospinal fluid adenosine deaminase activity: a complimentary tool in the early diagnosis of tuberculous meningitis.

Authors:  Rajpal S Kashyap; Rani P Kainthla; Anju V Mudaliar; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Cerebrospinal Fluid Res       Date:  2006-03-30

7.  Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy.

Authors:  T S Fröde; Y S Medeiros
Journal:  Mediators Inflamm       Date:  2001-08       Impact factor: 4.711

8.  Cryptococcal meningitis associated with increased adenosine deaminase in the cerebrospinal fluid.

Authors:  Yuji Tanaka; Kazuo Satomi
Journal:  Springerplus       Date:  2016-12-12

9.  Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.

Authors:  Ajay Amit; Manas R Dikhit; Raj K Pandey; Kuljit Singh; Ritesh Mishra; V N R Das; Pradeep Das; Sanjiva Bimal
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

Review 10.  Biomarkers of Cutaneous Leishmaniasis.

Authors:  Fariborz Bahrami; Ali M Harandi; Sima Rafati
Journal:  Front Cell Infect Microbiol       Date:  2018-06-26       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.